Clinical Research Center Limited liability company Medic-R Limited partnership

Poznan 61-737

0 studies enrolling now · 1 studies all time

What they study most

Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder

Studies at this site

• A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer — Running, not enrolling